gene therapy regulation FDA

FDA guidance updates for emerging biotechnologies continue to shape how innovative therapies and advanced biological platforms move from laboratory research to regulated clinical use in the United States. As new therapeutic modalities advance rapidly, the regulatory environment must evolve to address scientific complexity, manufacturing challenges, and long-term patient safety considerations. In recent years, the US … Read more